24
Oct
2023

Biosidus

Exhibitor at CPHI Barcelona 2023 stand 81F30, API
About Us

Biosidus is engaged in the development, manufacturing and commercialization of high-quality recombinant proteins. Since the launch of Erythropoetin in 1990, Biosidus has successively marketed the following biosimilars: Interferon Alfa 2a, Interferon Alfa 2b, Filgrastim, Somatropin, Lenograstim, Azacitidine, Bortezomib, Interferon beta 1a (SC and IM) and Teriparatide. Today, these products are being commercialized in more than 50 markets.
With headquarters and manufacturing plants located in Buenos Aires, Argentina, we have developed regional hubs in order to intensify our pres...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • AR
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Biopharmaceutical company
Generics/Biosimilars Manufacturer
Primary activities
Biopharmaceutical
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Barcelona 2023
  • 24-26 October 2023
  • Fira Barcelona Gran Via, Spain
  • Visit us at stand 81F30, API

Products Featured at CPHI Barcelona 2023